WuXi Biologics (Cayman) Inc. Depositary Receipt (WUXI13)
Market Closed
12 Jun, 23:30
SET SET Primary ฿
1. 92
+0.09
+4.918%
฿
558.61B Market Cap
15.48 P/E Ratio
- Div Yield
11 Volume
0 Eps
฿ 1.83
Previous Close Want to track WUXI13 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
WuXi Biologics (Cayman) Inc. Depositary Receipt (WUXI13) Statistics
Valuation metrics
Market Cap 558.61B
Enterprise value 8.02B
Trailing P/E (ttm) 0.37
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.39
Price/Book (mrq) 0.04
Enterprise Value/Revenue 0.08
Enterprise Value/EBITDA 0.21
Overview
Shares outstanding 4.13B
Float 3.74B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 647
Average volume (90 days) 1.53K
Price summary
52-Week low 1.8
52-Week high 2.62
Beta 0.58
50-Day moving average 2.2
200-Day moving average 2.12
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.23%
Operating margin 0.33%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.12%
Income Statement
Revenue (ttm) 104.16B
Revenue per share (ttm) 10.82
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 47.89B
EBITDA 8.49B
Net income to common (ttm) 23.46B
Diluted EPS (ttm) 5.56
Quarterly earnings growth (yoy) 0.38%
Balance Sheet
Total cash (mrq) 75.21B
Total cash per share (mrq) 3.81
Total debt (mrq) 14.84B
Total Debt/Equity (mrq) 5.85
Current ratio (mrq) 3.39%
Book value per share (mrq) 53.96
Cash Flow
Cash flow statement 30.31B
Levered free cash flow (LFCF) 20.48B
